van Beek I - Search Results

1

Treating Addictions: Harm Reduction in Clinical Care and Prevention.

Drucker E, Anderson K, Haemmig R, Heimer R, Small D, Walley A, Wood E, van Beek I. Drucker E, et al. Among authors: van beek i. J Bioeth Inq. 2016 Jun;13(2):239-49. doi: 10.1007/s11673-016-9720-6. Epub 2016 Apr 26. J Bioeth Inq. 2016. PMID: 27112489

2

Harm reduction--an ethical imperative.

Van Beek I. Van Beek I. Addiction. 2009 Mar;104(3):342-3; discussion 345-6. doi: 10.1111/j.1360-0443.2008.02418.x. Addiction. 2009. PMID: 19207339 No abstract available.

3

An overview of take-home naloxone programs in Australia.

Dwyer R, Olsen A, Fowlie C, Gough C, van Beek I, Jauncey M, Lintzeris N, Oh G, Dicka J, Fry CL, Hayllar J, Lenton S. Dwyer R, et al. Among authors: van beek i. Drug Alcohol Rev. 2018 May;37(4):440-449. doi: 10.1111/dar.12812. Drug Alcohol Rev. 2018. PMID: 29744980

4

A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.

Shearer J, Darke S, Rodgers C, Slade T, van Beek I, Lewis J, Brady D, McKetin R, Mattick RP, Wodak A. Shearer J, et al. Among authors: van beek i. Addiction. 2009 Feb;104(2):224-33. doi: 10.1111/j.1360-0443.2008.02437.x. Addiction. 2009. PMID: 19149817 Clinical Trial.

5

The Australasian Professional Society on Alcohol and Other Drugs: from a cottage industry to a regional player.

van Beek I, Saunders JB, Roche AM. van Beek I, et al. Addiction. 2007 Feb;102(2):191-6. doi: 10.1111/j.1360-0443.2006.01662.x. Addiction. 2007. PMID: 17222272 No abstract available.

6

The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.

Salmon AM, van Beek I, Amin J, Kaldor J, Maher L. Salmon AM, et al. Among authors: van beek i. Addiction. 2010 Apr;105(4):676-83. doi: 10.1111/j.1360-0443.2009.02837.x. Epub 2010 Feb 9. Addiction. 2010. PMID: 20148794

7

Some characteristics of early-onset injection drug users prior to and at the time of their first injection.

Abelson J, Treloar C, Crawford J, Kippax S, van Beek I, Howard J. Abelson J, et al. Among authors: van beek i. Addiction. 2006 Apr;101(4):548-55. doi: 10.1111/j.1360-0443.2006.01379.x. Addiction. 2006. PMID: 16548934

8

Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence.

Shearer J, Wodak A, van Beek I, Mattick RP, Lewis J. Shearer J, et al. Among authors: van beek i. Addiction. 2003 Aug;98(8):1137-41. doi: 10.1046/j.1360-0443.2003.00447.x. Addiction. 2003. PMID: 12873248 Clinical Trial.

9

Does training people to administer take-home naloxone increase their knowledge? Evidence from Australian programs.

Dietze PM, Draper B, Olsen A, Chronister KJ, van Beek I, Lintzeris N, Dwyer R, Nelson M, Lenton S. Dietze PM, et al. Among authors: van beek i. Drug Alcohol Rev. 2018 May;37(4):472-479. doi: 10.1111/dar.12680. Epub 2018 Feb 22. Drug Alcohol Rev. 2018. PMID: 29473245

10

Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial.

Dietze P, Jauncey M, Salmon A, Mohebbi M, Latimer J, van Beek I, McGrath C, Kerr D. Dietze P, et al. Among authors: van beek i. JAMA Netw Open. 2019 Nov 1;2(11):e1914977. doi: 10.1001/jamanetworkopen.2019.14977. JAMA Netw Open. 2019. PMID: 31722024 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page